期刊文献+

蜂蜡素固体分散体对高脂血症大鼠脂代谢的影响 被引量:1

Effect of Fenglasu solid dispersion on lipid metabolism in hyperlipoidemia rats
原文传递
导出
摘要 目的:观察蜂蜡素(Fenglasu,FLS)及蜂蜡素固体分散体(Fenglasu solid dispersion,FLS-SD)对高脂血症大鼠脂代谢的影响。方法:高脂饲料喂养制备高脂血症大鼠模型,分别给予高,中,低剂量FLS及FLS-SD(50,100,200 mg·kg-1·d-1),测定大鼠血清中胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、载脂蛋白A1(apoA1)、载脂蛋白B100(apoB100)含量,计算LDL-C/HDL-C和apoA1/apoB100的比值。结果:FLS及FLS-SD均呈剂量和时间依赖性显著降低高血脂大鼠血清TC,TG,LDL-C,apoB100和LDL-C/HDL-C比值,显著升高HDL-C、apoA1和apoA1/apoB100比值,且FLS-SD作用强于FLS。结论:FLS-SD可有效调节高脂血症大鼠的脂代谢紊乱。 Objective: To observe the effects of Fenglasu (FLS) and Fenglasu solid dispersion (FLS-SD) on lipid metabolism in byperlipoidemia rats. Methods: Hyperlipoidemia rat was induced by feeding with high lipid diets, and FLS and FLS-SD (50, 100, 200 mg·kg^-l·d^-1) were preventively administered. TC, TG, LDL-C, HDL-C, apoA1, and apoB100 were determined, LDL-C/HDL-C and apoA1/apoBlo0 were calculated. Results: FLS and FLS-SD decreased the levels of TC, TG, LDL-C, apoB1oo , and LDL-C/HDL-C ; increased the levels of HDL- C, apoA1 , apoA1/apoBl00 in dose- and time-dependent manners. The effect of FLS-SD was more potent than that of FLS. Conclusion: FLS-SD can effectively adjust lipid metabolic disorder in hyperlipoidemia rats.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第11期1034-1037,共4页 Chinese Journal of New Drugs
关键词 蜂蜡素 固体分散体 高脂血症 脂代谢 Fenglasu solid dispersion hyperlipoidemia lipid metabolism
  • 相关文献

参考文献7

二级参考文献36

  • 1廖芳,张小娜.新型降胆固醇药物蜂蜡素胶囊[J].中国药师,2005,8(12):1039-1040. 被引量:9
  • 2王家政 范明.蛋白质技术手册[M].北京:科学技术出版社,2000.51-54. 被引量:12
  • 3TEUPSER D, BRUEGEL M, STEIN O, etal. HMG-CoAreductase inhibitors reduce adhesion of human monocytes to endothelial cells[J]. Biochem Biophys Res Commun, 2001, 289(4) :838 - 844. 被引量:1
  • 4刘斌,王为.细胞培养[M].西安:世界图书出版西安公司,2005:235-257 被引量:1
  • 5Choice of lipid-regulating drugs[ J ]. Med Lett Drugs Ther, 2001, 43(1105): 43-48. 被引量:1
  • 6KNOPP RH. Drug treatment of lipid disorders[ J]. N Engl J Med, 1999, 341(7) :498 -511. 被引量:1
  • 7PAOLETTI R, FAHMY M, MAHLA G, et al. Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterotaemic patients : a randomized, double-blind study [ J ]. J Cardiovasc Risk, 2001,8 ( 6 ) : 383 - 390. 被引量:1
  • 8DAVIDSON MH. Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia [J]. Expert Opin lnvestig Drugs, 2002, 11(3) :125 -141. 被引量:1
  • 9DIMITROULAKOS J, NOHYNEK D, BACKWAY KL, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach [J]. Blood, 1999, 93(4) :1308-1318. 被引量:1
  • 10DUCOBU J. Hypercholesterolemia: to treat or not to treat? That is the question[J]. Rev Med Brux, 1994, 15(3) :124-131. 被引量:1

共引文献8

同被引文献15

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部